894
Views
10
CrossRef citations to date
0
Altmetric
Commentary

Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe?

A rotavirus case study

, , &
Pages 2290-2294 | Received 22 Apr 2014, Accepted 01 May 2014, Published online: 08 May 2014

References

  • Postma MJ, Standaert BA. Economics of vaccines revisited. Hum Vaccin Immunother 2013; 9:1139 - 41; http://dx.doi.org/10.4161/hv.23447; PMID: 23364247
  • Aballéa S, Millier A, Quilici S, Caroll S, Petrou S, Toumi M. A critical literature review of health economic evaluations of rotavirus vaccination. Hum Vaccin Immunother 2013; 9:1272 - 88; http://dx.doi.org/10.4161/hv.24253; PMID: 23571226
  • Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis 1991; 13:448 - 61; http://dx.doi.org/10.1093/clinids/13.3.448; PMID: 1866549
  • Morgan C, Adlard N, Carroll S, Parvataneni L. Burden on UK secondary care of rotavirus disease and seasonal infections in children. Curr Med Res Opin 2010; 26:2449 - 55; http://dx.doi.org/10.1185/03007995.2010.518135; PMID: 20818925
  • Wildi-Runge S, Allemann S, Schaad UB, Heininger U. A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur J Pediatr 2009; 168:1343 - 8; http://dx.doi.org/10.1007/s00431-009-0934-z; PMID: 19205732
  • Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 2004; 22:Suppl 1 S49 - 54; http://dx.doi.org/10.1016/j.vaccine.2004.08.017; PMID: 15576202
  • Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25:Suppl S7 - 11; http://dx.doi.org/10.1097/01.inf.0000197622.98559.01; PMID: 16397431
  • Festini F, Cocchi P, Mambretti D, Tagliabue B, Carotti M, Ciofi D, Biermann KP, Schiatti R, Ruggeri FM, De Benedictis FM, et al. Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis 2010; 10:235; http://dx.doi.org/10.1186/1471-2334-10-235; PMID: 20696065
  • Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, Giaquinto C, Grimprel E. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006; 25:Suppl S12 - 21; http://dx.doi.org/10.1097/01.inf.0000197563.03895.91; PMID: 16397425
  • Verhagen P, Moore D, Manges A, Quach C. Nosocomial rotavirus gastroenteritis in a Canadian paediatric hospital: incidence, disease burden and patients affected. J Hosp Infect 2011; 79:59 - 63; http://dx.doi.org/10.1016/j.jhin.2011.04.020; PMID: 21723643
  • Widdowson MA, van Doornum GJ, van der Poel WH, de Boer AS, van de Heide R, Mahdi U, Haanen P, Kool JL, Koopmans M. An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods. Infect Control Hosp Epidemiol 2002; 23:665 - 70; http://dx.doi.org/10.1086/501991; PMID: 12452294
  • Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011; 127:e264 - 70; http://dx.doi.org/10.1542/peds.2010-1830; PMID: 21262887
  • Hartwig S, Uhari M, Renko M, Hemming M, Vesikari T. Bed occupancy for rotavirus gastroenteritis in two Finnish hospitals before and after the implementation of the vaccination program with Rotateq. European Society for Paediatric Infectious Diseases. 2014. Ref Type: Conference Proceeding.
  • Alwan A, Strens D, Raes M, Standaert B. Improvement in hospital quality of care after the introduction of rotavirus vaccination: a pilot study in Belgium. 2013. Ref Type: Conference Proceeding.
  • Van der Wielen M, Giaquinto C, Gothefors L, Huelsse C, Huet F, Littmann M, Maxwell M, Talayero JM, Todd P, Vila MT, et al, REVEAL Study Group. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract 2010; 11:22; http://dx.doi.org/10.1186/1471-2296-11-22; PMID: 20230601
  • Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011; 30:Suppl S1 - 5; http://dx.doi.org/10.1097/INF.0b013e3181fefa1f; PMID: 21183833
  • Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr 2013; 172:739 - 46; http://dx.doi.org/10.1007/s00431-013-1945-3; PMID: 23361964
  • Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine 2012; 30:6766 - 76; http://dx.doi.org/10.1016/j.vaccine.2012.09.025; PMID: 23000223
  • Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy]. Ann Ig 2013; 25:43 - 56; PMID: 23435779

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.